Karyana, Muhammad http://orcid.org/0000-0002-7785-5731
Djaharuddin, Irawaty
Rif’ati, Lutfah
Arif, Mansyur
Choi, Mi Kyung
Angginy, Nova
Yoon, Aeri
Han, Jumi
Josh, Fonny
Arlinda, Dona
Narulita, Asvin
Muchtar, Faisal
Bakri, Rizki Auliah
Irmansyah, s
Funding for this research was provided by:
Daewoong Infion
Article History
Received: 26 November 2021
Accepted: 26 January 2022
First Online: 1 April 2022
Declarations
:
: All participants have given informed consent. Ethical clearance (LB.02.01/KE.443/2020) was obtained from the NIHRD EC.
: All participants have given written informed consent for the publication of their information. All authors have reviewed and approved the manuscript and have given their permission for submission.
: The author(s) declared potential conflicts of interest with respect to the research, authorship, and/or publication of this article. Jumi Han, Aeri Yoon, and Mi Kyung Choi being employed by Daewoong Pharmaceutical Co Ltd; and Nova Angginy, being employed by Daewoong Infion. Authors from Daewoong were not involved in data collection and analysis. No other potential conflict of interest relevant to this article was reported.